{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:11:06Z","timestamp":1780387866122,"version":"3.54.1"},"reference-count":50,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2663840","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:49:43Z","timestamp":1780386583000},"page":"1579-1594","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The productivity losses due to cancer mortality and morbidity in 13 Asia-Pacific geographies across 2010, 2015, 2019, and 2022"],"prefix":"10.1080","volume":"29","author":[{"given":"Manoj","family":"Gambhir","sequence":"first","affiliation":[{"name":"Health Economics and Decision Sciences Regional, MSD (Australia) Pty Ltd","place":["Macquarie Park, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athar Hasan","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Meiwald","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamath","family":"Perera","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Fox","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Gokhale","sequence":"additional","affiliation":[{"name":"Value and Implementation Outcomes Research Regional, MSD Pharmaceuticals Private Limited","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_3_1","unstructured":"United Nations. Department of Economic and Social Affairs Population Division. World Population Ageing 2019: Highlights (ST\/ESA\/SER.a\/430). 2019."},{"issue":"3","key":"e_1_3_5_4_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray FA-O","year":"2024","unstructured":"Bray FA-O, Laversanne M, Sung HA-O, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263.","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_5_5_1","unstructured":"World Health Organization. Cancer tomorrow. Estimated number of new cases from 2022 to 2050 Both sexes age [0-85+]. 2022. [cited 2025 28th May]. Available from: https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/bars?types=0&sexes=0&mode=population&group_populations=0&multiple_populations=1&multiple_cancers=1&cancers=39&populations=935&apc=cat_ca20v1.5_ca23v-1.5&group_cancers=1&years=2050"},{"key":"e_1_3_5_6_1","unstructured":"World Cancer Research Fund. Lung cancer statistics. [cited 2025 May 28]. Available from: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/lung-cancer-statistics\/#:\u223c:text=Lung%20cancer%20deaths- China%2C%20the%20US%20and%20Japan%20had%20the%20highest%20number%20of from%20lung%20cancer%20in%202022"},{"issue":"11","key":"e_1_3_5_7_1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Lei S","year":"2021","unstructured":"Lei S, Zheng RA-O, Zhang SA-O, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183\u20131194.","journal-title":"Cancer Commun (Lond)"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.7826"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.5301\/grhta.5000262"},{"key":"e_1_3_5_10_1","doi-asserted-by":"crossref","unstructured":"Donkor A Atuwo-Ampoh VD Yakanu F et al. Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis. Support Care Cancer. 2022;30(9):7159\u20137190. doi: 10.1007\/s00520-022-07044-z","DOI":"10.1007\/s00520-022-07044-z"},{"key":"e_1_3_5_11_1","doi-asserted-by":"crossref","unstructured":"Park EH Jung KW Park NJ et al. Community of population-based regional cancer registries. Cancer statistics in Korea: incidence mortality survival and prevalence in 2022. Cancer Res Treat. 2025;57(2):312\u2013330. doi: 10.4143\/crt.2025.264.","DOI":"10.4143\/crt.2025.264"},{"key":"e_1_3_5_12_1","doi-asserted-by":"crossref","unstructured":"Huang J Ngai CH Deng Y et al. Cancer incidence and mortality in Asian countries: a trend analysis. Cancer Control. 2022;29:10732748221095955. doi: 10.1177\/10732748221095955.","DOI":"10.1177\/10732748221095955"},{"key":"e_1_3_5_13_1","doi-asserted-by":"crossref","unstructured":"Brand NR Qu LG Chao A et al. Delays and barriers to cancer care in low- and middle-income countries: a systematic review. Oncologist. 2019;24(12):e1371-e1380. doi: 10.1634\/theoncologist.2019-0057.","DOI":"10.1634\/theoncologist.2019-0057"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6"},{"key":"e_1_3_5_16_1","unstructured":"World Health Organization. WHO South-East Asia Regional Strategy for comprehensive cancer prevention and management 2024\u20132030. New Delhi; 2024."},{"key":"e_1_3_5_17_1","unstructured":"The Economist Intelligence Unit. Controlling cancer: the state of national cancer control plans in Asia. 2015."},{"key":"e_1_3_5_18_1","doi-asserted-by":"crossref","unstructured":"Yip CH Cazap E Anderson BO et al. Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast. 2011;20 Suppl 2:S12-9. doi: 10.1016\/j.breast.2011.02.015.","DOI":"10.1016\/j.breast.2011.02.015"},{"key":"e_1_3_5_19_1","doi-asserted-by":"crossref","unstructured":"Hanly P Soerjomataram I Sharp L. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2015;136:E136-E145. doi: 10.1002\/ijc.29105","DOI":"10.1002\/ijc.29105"},{"key":"e_1_3_5_20_1","doi-asserted-by":"crossref","unstructured":"Ortega-Ortega M Hanly P Pearce A et al. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. Int J Cancer. 2022;150(4):580\u2013593. doi: 10.1002\/ijc.33826.","DOI":"10.1002\/ijc.33826"},{"key":"e_1_3_5_21_1","doi-asserted-by":"crossref","unstructured":"Bencina G Gambhir M Sukarom I et al. The indirect costs and burden of vaccine-preventable cancers premature mortality in Asia-Pacific countries. J Med Econ. 2024;27(sup2):51\u201361. doi: 10.1080\/13696998.2025.2468120","DOI":"10.1080\/13696998.2025.2468120"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2169497"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02509-x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2024.100499"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2368986"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2341572"},{"key":"e_1_3_5_27_1","unstructured":"The World Bank. Indicator: GNI per capita. Atlas method (current US$). 2022. NY.GNP.PCAP.CD [cited 2025 Feb 17]. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GNP.PCAP.CD"},{"key":"e_1_3_5_28_1","unstructured":"The Institute for Health Metrics and Evaluation (IHME). 2022. Data from: mortality."},{"key":"e_1_3_5_29_1","unstructured":"Global Burden of Disease Collaborative Network. 2024. Global Burden of Disease Study 2021 (GBD 2021). In: (IHME) IfHMaE editor."},{"key":"e_1_3_5_30_1","unstructured":"The World Bank. Population: male and female. [cited 2024 Oct 14]. Available from: https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL.MA.IN"},{"key":"e_1_3_5_31_1","unstructured":"The World Bank. Pension age at which men and women can retire with full pension benefits 2022. [cited 2024 May 1]. Available from: https:\/\/wbl.worldbank.org\/en\/data\/exploretopics\/wbl_gpen"},{"key":"e_1_3_5_32_1","unstructured":"The World Bank. Unemployment rate by age 2022. [cited 2024 Jul 23]. Available from: https:\/\/databank.worldbank.org\/source\/world-development-indicators#"},{"key":"e_1_3_5_33_1","unstructured":"Department of Household Registration-M.O.I. Table 1. Population by sex and 5 year age group for counties and cities 2024 [cited 2025 Jun]. Available from: https:\/\/www.ris.gov.tw\/app\/en\/3910"},{"key":"e_1_3_5_34_1","unstructured":"ILOSTAT. Average monthly earnings of employees by sex and economic activity (local currency) \u2013 total values. [cited 2024 Jul 24]. Available from: https:\/\/ilostat.ilo.org\/topics\/wages\/."},{"key":"e_1_3_5_35_1","unstructured":"ILOSTAT. Unemployment total (% of total labor force). (modeled ILO estimate). Available from: https:\/\/data.worldbank.org\/indicator\/SL.UEM.TOTL.ZS"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00250-7"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.03.001"},{"key":"e_1_3_5_38_1","doi-asserted-by":"crossref","unstructured":"Sharma D Prinja S Aggarwal AK et al. Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment. Lancet Reg Health Southeast Asia. 2023;16:100241. doi: 10.1016\/j.lansea.2023.100241","DOI":"10.1016\/j.lansea.2023.100241"},{"key":"e_1_3_5_39_1","unstructured":"Department of Science and Technology (DOST). Philippine Health Technology Assessment (HTA) Methods Guide on the Assessment of Clinical Equipment and Devices. 2023."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-3"},{"key":"e_1_3_5_41_1","doi-asserted-by":"crossref","unstructured":"Choi E Jun JK Suh M et al. Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality. NPJ Breast Cancer. 2021;7(1):83. doi: 10.1038\/s41523-021-00295-9.","DOI":"10.1038\/s41523-021-00295-9"},{"key":"e_1_3_5_42_1","doi-asserted-by":"crossref","unstructured":"Han KT Jun JK Im JS. National cancer control plan of the Korea: current status and the fourth plan (2021-2025). J Prev Med Public Health. 2023;56(3):205\u2013211. doi: 10.3961\/jpmph.23.115.","DOI":"10.3961\/jpmph.23.115"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2018.03.004"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033427"},{"key":"e_1_3_5_45_1","unstructured":"Disparities in availability of new cancer drugs worldwide: 1990-2022 [Internet]. BMJ Global Health. 2024. Available from: https:\/\/bmjgroup.com\/significant-worldwide-disparities-in-availability-and-timeliness-of-new-cancer-drugs\/"},{"key":"e_1_3_5_46_1","doi-asserted-by":"crossref","unstructured":"How SH Liam CK Zainal Abidin MA et al. Outcomes of patients with EGFR-mutant advanced NSCLC in a developing country in Southeast Asia. Cancer Manag Res. 2022;14:1995\u20132005. doi: 10.2147\/CMAR.S364713.","DOI":"10.2147\/CMAR.S364713"},{"key":"e_1_3_5_47_1","doi-asserted-by":"crossref","unstructured":"Kumar S Joga S Biswas B et al. Immune checkpoint inhibitors in advanced non-small cell lung cancer: a metacentric experience from India. Curr Probl Cancer. 2020;44(3):100549. doi: 10.1016\/j.currproblcancer.2020.100549.","DOI":"10.1016\/j.currproblcancer.2020.100549"},{"key":"e_1_3_5_48_1","doi-asserted-by":"crossref","unstructured":"Patil V Abraham G Ravikrishna M et al. Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India. Ecancermedicalscience. 2022;16:1464. doi: 10.3332\/ecancer.2022.1464.","DOI":"10.3332\/ecancer.2022.1464"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2023.07.007"},{"key":"e_1_3_5_50_1","doi-asserted-by":"crossref","unstructured":"Ginsburg O Bray F Coleman MP et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847\u2013860. doi: 10.1016\/S0140-6736(16)31392-7.","DOI":"10.1016\/S0140-6736(16)31392-7"},{"key":"e_1_3_5_51_1","doi-asserted-by":"crossref","unstructured":"Kimman M Jan S Fau-Kingston D Kingston D Fau-Monaghan H et al. Socioeconomic impact of cancer in member countries of the Association of Southeast Asian Nations (ASEAN): the ACTION study protocol. Asian Pac J Cancer Prev. 2012;13(2):421\u2013425.","DOI":"10.7314\/APJCP.2012.13.2.421"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2663840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:49:59Z","timestamp":1780386599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2663840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2663840"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2663840","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}